TY - JOUR
T1 - Induction and function of type i and III interferon in response to viral infection
AU - Levy, David E.
AU - Marié, Isabelle J.
AU - Durbin, Joan E.
N1 - Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2011/12
Y1 - 2011/12
N2 - The type I and III interferon (IFN) families consist of cytokines rapidly induced during viral infection that confer antiviral protection on target cells and are critical components of innate immune responses and the transition to effective adaptive immunity. The regulation of their expression involves an intricate and stringently regulated signaling cascade, initiated by recognition most often of viral nucleic acid in cytoplasmic and endosomal compartments and involving a series of protein conformational rearrangements and interactions regulated by helicase action, ubiquitin modification, and protein aggregation, culminating in kinase activation and phosphorylation of critical transcription factors and their regulators. The many IFN subtypes induced by viruses confer amplification, diversification, and cell-type specificity to the host response to infection, providing fertile ground for development of antiviral therapeutics and vaccines.
AB - The type I and III interferon (IFN) families consist of cytokines rapidly induced during viral infection that confer antiviral protection on target cells and are critical components of innate immune responses and the transition to effective adaptive immunity. The regulation of their expression involves an intricate and stringently regulated signaling cascade, initiated by recognition most often of viral nucleic acid in cytoplasmic and endosomal compartments and involving a series of protein conformational rearrangements and interactions regulated by helicase action, ubiquitin modification, and protein aggregation, culminating in kinase activation and phosphorylation of critical transcription factors and their regulators. The many IFN subtypes induced by viruses confer amplification, diversification, and cell-type specificity to the host response to infection, providing fertile ground for development of antiviral therapeutics and vaccines.
UR - http://www.scopus.com/inward/record.url?scp=82955163285&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=82955163285&partnerID=8YFLogxK
U2 - 10.1016/j.coviro.2011.11.001
DO - 10.1016/j.coviro.2011.11.001
M3 - Review article
C2 - 22323926
AN - SCOPUS:82955163285
VL - 1
SP - 476
EP - 486
JO - Current Opinion in Virology
JF - Current Opinion in Virology
SN - 1879-6257
IS - 6
ER -